Comparison of Triggers in Double Ovarian Stimulation (DuoStim).
Launched by INSTITUTO BERNABEU · Apr 4, 2022
Trial Information
Current as of May 04, 2025
Unknown status
Keywords
ClinConnect Summary
No description provided
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • BMI below 32
- • Presence of both ovaries
- • Indication for ovarian stimulation under Double Stimulation protocol (Duo Stim)
- • Meeting the criteria for Duo Stim
- • Medical history, history and physical examination without alterations
- • AMH and AFV results in accordnace to Poseidon classification group 3 or 4 no more than 6 months prior to signing the consent form
- • Ability to participate and comply with the study protocol.
- • To have given written consent
- • Normal karyotype and fragile X.
- Exclusion Criteria:
- • Non-compliance with instructions and/or non-formalization of consents or legal requirements for IVF.
- • Concurrent participation in another study
About Instituto Bernabeu
Instituto Bernabeu is a leading reproductive health and fertility clinic dedicated to providing advanced medical care and innovative treatments for individuals and couples seeking to conceive. With a focus on evidence-based practices and cutting-edge technologies, the institute specializes in assisted reproductive techniques, including in vitro fertilization (IVF), gamete donation, and fertility preservation. Renowned for its commitment to patient-centered care, Instituto Bernabeu combines clinical excellence with a compassionate approach, ensuring that each patient's unique needs are met throughout their fertility journey. As a sponsor of clinical trials, the institute actively contributes to the advancement of reproductive medicine and the development of new therapeutic options.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Alicante, , Spain
Palma De Mallorca, Mallorca, Spain
Albacete, , Spain
Madrid, , Spain
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials